Analyst Ratings for NovoCure Ltd. (NVCR)
NVCR Rating Summary
NVCR Price Target Summary
- Highest: $47.00 (H.C. Wainwright)
- Lowest: $13.50 (Wells Fargo)
- Average: $27.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$27.50 (+110.9%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 69%
Avg. $ Target:
$27.50 (+110.9%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/25/2025 | Wells Fargo » Updated 12/12/2025 |
Larry Biegelsen | Downgrade | Equal Weight (Overweight) |
13.50 (14.50) |
16.51 (13.04) |
-21.02% | Details |
| 7/8/2025 | Ladenburg Thalmann » Updated 10/31/2025 |
Kevin DeGeeter | New Coverage | Buy (N/A) |
27.00 (30.00) |
16.89 (13.04) |
-22.79% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
